Gastrointestinal Bleeding in Antithrombotic Therapy in Patients with Coronary Heart Disease: Risk Factors, Pathogenesis and Treatment

Autor: N. S. Lapina, A. A. Alekseeva, A. D. Vershinina, N. S. Khruleva, F. N. Muradova, L. Y. Koroleva

Publikováno v: Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 30, Iss 3, Pp 14-23 (2020)

Aim. Description of risk factors, pathogenesis and treatment strategies of gastrointestinal bleeding (GIB) in the course of antithrombotic therapy in patients with coronary heart disease (CHD).Key points. Risk factors of GIB during antithrombotic the

Externí odkaz: https://doaj.org/article/e9a04f339ce44dd28130f316f6e09f91

Atrial Flutter: up‐to‐date Problem Evaluation with Clinical Positions

Autor: N V Amineva, V P Nosov, K V Potapova, L Y Koroleva

Publikováno v: Kardiologiia. 60:70-80

The review provides current ideas about the etiology and prevalence of atrial flutter (AF), mechanism and substrate of arrhythmogenesis, and principles of clinical and electrophysiological classification of this arrhythmia. Methods for conservative a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01a080a903f6c84e1ff851f0c39c2dda
https://doi.org/10.18087/cardio.2020.1.n693

Issues of antithrombotic therapy in ACS patients with atrial fibrillation

Autor: A. M. Koryazina, G V Kovaleva, A T Volkova, N N Paykova, L Y Koroleva, V P Nosov, N A Kaydalova

Publikováno v: Kardiologiia. 17:22-30

The review analyzed current ideas on prevalence and clinical significance of atrial fibrillation following acute coronary syndrome; described modern approaches to administration of antithrombotic therapy; and addressed available clinical studies on t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f1ce48a8de90783f949a490a07d7cb19
https://doi.org/10.18087/cardio.2422

[Issues of antithrombotic therapy in ACS patients with atrial fibrillation]

Autor: N A, Kaydalova, L Y, Koroleva, G V, Kovaleva, N N, Paykova, V P, Nosov, A T, Volkova, A M, Koryazina

Publikováno v: Kardiologiia. (S1)

The review analyzed current ideas on prevalence and clinical significance of atrial fibrillation following acute coronary syndrome; described modern approaches to administration of antithrombotic therapy; and addressed available clinical studies on t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::15f3ee13eb60728d1d02ada71866bc34
https://pubmed.ncbi.nlm.nih.gov/29768158

PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD

Autor: E. S. Timoschenko, L. Y. Koroleva, I. I. Gritsenko, V. P. Nosov, I. V. Kolesnichenko

Publikováno v: Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 10, Iss 3, Pp 303-306 (2015)
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 11, Iss 6, Pp 303-306 (2015)

Adequate primary and secondary prevention of thromboembolic complications is one of the main goals of management of patients with atrial fibrillation. Many years of practice and experience of warfarin use, unfortunately, did not lead to wider and mor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae7fac03bea5116d868c9fa53bca46d6
https://www.rpcardio.com/jour/article/view/242